Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Mylan N.V. (MYL)

18.53   0.92 (5.22%) 08-16 16:00
Open: 17.88 Pre. Close: 17.61
High: 18.6088 Low: 17.6846
Volume: 5,361,750 Market Cap: 9559M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 18.637 - 18.741 18.741 - 18.836
Low: 17.411 - 17.544 17.544 - 17.666
Close: 18.33 - 18.53 18.53 - 18.713

Technical analysis

as of: 2019-08-16 4:50:21 PM
Stoxline posted a NEUTRAL today, upgraded from lower rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 23.52     One year: 25.56
Support: Support1: 17.31    Support2: 14.40
Resistance: Resistance1: 20.13    Resistance2: 21.88
Pivot: 19.39
Moving Average: MA(5): 18.61     MA(20): 19.16
MA(100): 21.27     MA(250): 27.89
MACD: MACD(12,26): -0.15     Signal(9): 0.01
Stochastic oscillator: %K(14,3): 16.41     %D(3): 25.89
RSI: RSI(14): 47.04
52-week: High: 39.59  Low: 16.63  Change(%): -51.4
Average Vol(K): 3-Month: 815646  10-Days: 810447

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
MYL has closed above bottom band by 30.1%. Bollinger Bands are 11.6% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Thu, 15 Aug 2019 15:20:42 Z
Company News For Aug 15, 2019

Wed, 14 Aug 2019 20:49:55 Z
Market Close Report: NASDAQ Composite index closes at 7,773.94 down -242.42 points

Wed, 14 Aug 2019 16:15:40 Z
Should Value Investors Pick Mylan N.V. (MYL) Stock?

Wed, 14 Aug 2019 15:07:54 Z
Nasdaq 100 Movers: MYL, KHC

Mon, 12 Aug 2019 16:12:16 Z
Amgen Wins Enbrel U.S. Patent Litigation Against Novartis

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare
Industry:  Drug Manufacturers - Specialty Generic
Shares Out. (M) 515.46
Shares Float (M) 512.76
% Held by Insiders 1.08
% Held by Institutions 86.25
Shares Short (K) 11890
Shares Short P. Month (K)

Stock Financials

EPS 0.060
EPS Est. Current Year 4.590
EPS Est. Next Year 5.330
EPS Est. Next Quarter 1.360
Forward EPS 5.850
Book Value (p.s.) 23.070
PEG Ratio 0.97
Profit Margin 0.31
Operating Margin 14.68
Return on Assets (ttm) 3.2
Return on Equity (ttm) 0.3
Qtrly Rev. Growth 1.5
Gross Profit (p.s.) 8.866
Sales Per Share
EBITDA (p.s.) 6.887
Qtrly Earnings Growth
Operating Cash Flow (M) 1920.00
Levered Free Cash Flow (M) 2100.00

Stock Valuations

P/E 308.83
P/E Growth Ratio 0.05
P/BV 0.80
P/S 435742432.00
P/CF 4.97

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date 2007-06-27
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.